GSK plc Earnings
The next earnings date for GSK plc has not yet been scheduled.
Analyst Estimates of GSK plc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
GSK plc Earnings: Historical
| 10/28/2026 | Before Market | $1.47 | 5.00% |
| 07/28/2026 | Before Market | $1.36 | 7.09% |
| 04/29/2026 | Before Market | $1.26 | 8.62% |
| 02/04/2026 | Before Market | $0.70 | 12.90% |
| 10/29/2025 | Before Market | $1.46 | 15.87% |
| 07/30/2025 | Before Market | $1.24 | 11.71% |
| 04/30/2025 | Before Market | $1.20 | 15.38% |
| 02/05/2025 | Before Market | $0.58 | 18.37% |
| 10/30/2024 | Before Market | $1.29 | 11.21% |
| 07/31/2024 | Before Market | $1.11 | 13.27% |
More About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
“GSK plc Earnings” Can Refer to the GSK plc Earnings Date
Some people say “GSK plc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my GSK plc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning GSK plc Stock on the Earnings Date
If you own GSK plc stock (GSK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for GSK plc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading GSK plc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning GSK plc Options on the Earnings Date
If you own GSK plc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of GSK plc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own GSK plc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for GSK plc. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of GSK plc options often go down. This is sometimes referred to as volatility crush.
Learning More GSK plc Earnings
You can contact us any time if you would like to ask questions about GSK plc earnings or anything else related to the stock market.